UBX-303061

· Ubix Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for UBX-303061, covering 2025-11-19 to 2025-11-19. Get the full timeline:

Most recent: Clinical Trial Update: UBX-303061 in Subjects With Relapsed/Refractory B-Cell Malignancies [Phase 1]